TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17241410

Group type: EXPERIMENTAL
Intervention: 20 U botulinum toxin type A (BOTOX Cosmetic)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Number of subjects: 70
Study: 15159240

Group type: EXPERIMENTAL
Intervention: Food consumption during television viewing
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Fat content of foods consumed during television viewing
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Amount of food consumed during television viewing
Number of subjects: 2
Study: 11304662

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg once daily
Number of subjects: 810

Group type: COMPARATOR
Intervention: Rofecoxib 25 mg once daily
Number of subjects: 810
Study: 9629994

Group type: EXPERIMENTAL
Intervention: Mizolastine (10 mg o.d.) and digoxin (0.25 mg o.d.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo and digoxin (0.25 mg o.d.)
Number of subjects: 12
Study: 7948814

Group type: EXPERIMENTAL
Intervention: Patients with combined gastric body and duodenal ulcers
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Patients with combined gastric angular and duodenal ulcers
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Patients with combined gastric antral and duodenal ulcers
Number of subjects: 127

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 127
Study: 3063488

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 28797312

Group type: EXPERIMENTAL
Intervention: Self-perceived difficulties in performing IADLs
Number of subjects: 2802

Group type: COMPARATOR
Intervention: Cognitive tests of memory, reasoning, and speed of processing
Number of subjects: 2802
Study: 28929343

Group type: EXPERIMENTAL
Intervention: Isomaltulose (8% carbohydrate-electrolyte drink, 20 g h-1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Maltodextrin (8% carbohydrate-electrolyte drink, 20 g h-1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Carbohydrate (both isomaltulose and maltodextrin)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both carbohydrates (isomaltulose and maltodextrin)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (carbohydrate-energy-free)
Number of subjects: 22
Study: 25846721

Group type: EXPERIMENTAL
Intervention: Gla-300
Number of subjects: 807

Group type: COMPARATOR
Intervention: Gla-100
Number of subjects: 807
Study: 23596158

Group type: EXPERIMENTAL
Intervention: High Protein (HP) diet
Number of subjects: 253

Group type: COMPARATOR
Intervention: Low Protein (LP) diet
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) diet
Number of subjects: 253

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 253
Study: 21912346

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle fatigue (IMF) trial
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control trial
Number of subjects: 8
Study: 18199149

Group type: EXPERIMENTAL
Intervention: Powered toothbrush with triclosan dentifrice
Number of subjects: 128

Group type: COMPARATOR
Intervention: Manual toothbrush and standard dentifrice
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 128
Study: 16775595

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily
Number of subjects: 20
Study: 12809659

Group type: EXPERIMENTAL
Intervention: Knifelight group
Number of subjects: 82

Group type: COMPARATOR
Intervention: Open operation group
Number of subjects: 82
Study: 10807453

Group type: EXPERIMENTAL
Intervention: Primary angioplasty in diabetics (n = 81)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Primary angioplasty in nondiabetics (n = 391)
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Primary angioplasty in nondiabetics versus accelerated alteplase
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Primary angioplasty in diabetics versus accelerated alteplase
Number of subjects: 1138
Study: 8741719

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waiting-list group
Number of subjects: 36
Study: 1449044

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (r‐hGH) (0.1 IU/kg sc twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 2933055

Group type: EXPERIMENTAL
Intervention: PUVA combined with mechlorethamine (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mechlorethamine applied topically (group A)
Number of subjects: 40
Study: 30387163

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (300,000 IU)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 29413685

Group type: EXPERIMENTAL
Intervention: Cisplatin 25 mg/m2 and Gemcitabine 1000 mg/m2 with Panitumumab (arm A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cisplatin 25 mg/m2 and Gemcitabine 1000 mg/m2 without Panitumumab (arm B)
Number of subjects: 90
Study: 26789348

Group type: EXPERIMENTAL
Intervention: Metformin (M)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Carbohydrate-Modified Diet (CMD)
Number of subjects: 32
Study: 23937797

Group type: EXPERIMENTAL
Intervention: Low frequency BMBPC
Number of subjects: 23

Group type: COMPARATOR
Intervention: Medium frequency BMBPC
Number of subjects: 23
Study: 21289016

Group type: EXPERIMENTAL
Intervention: 15% carbamide peroxide (group B)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide (group C)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group (group A) with no alteration in dental colour
Number of subjects: 231
Study: 19231484

Group type: EXPERIMENTAL
Intervention: Modified capture rate (MCR) group with initial capture rate at 0.5 fps, modified to 2 fps after passing pylorus.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group with a constant capture rate of 2 fps.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Modified capture rate (MCR) group.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 50
Study: 17487649

Group type: EXPERIMENTAL
Intervention: CE/MPA 0.625/2.5 mg/day
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: CE/MPA 0.45/1.5 mg/day
Number of subjects: 1028

Group type: EXPERIMENTAL
Intervention: CE/MPA 0.3/1.5 mg/day
Number of subjects: 1028
Study: 16205431

Group type: EXPERIMENTAL
Intervention: Supervised treadmill training for 12 weeks
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 98
Study: 11837705

Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANNs) for predictive PK and PD modeling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naive averaging (NA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomly generated numbers (RN)
Number of subjects: 0
Study: 11072423

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine gum
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 608
Study: 7782257

Group type: EXPERIMENTAL
Intervention: Enoxacin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Co-trimoxazole
Number of subjects: 32
Study: 1910887

Group type: EXPERIMENTAL
Intervention: Collaborative learning model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional curriculum
Number of subjects: 0
Study: 7033014

Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide (Navidrex)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Sustained release oxprenolol (Slow‐Trasicor)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Fixed combination of cyclopenthiazide and oxprenolol (Trasidrex)
Number of subjects: 648

Group type: COMPARATOR
Intervention: Control group (previous treatment discontinued)
Number of subjects: 648
Study: 31289019

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Major infections
Number of subjects: 1800
Study: 30447975

Group type: EXPERIMENTAL
Intervention: Lycopene-enriched ice cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control ice cream
Number of subjects: 0
Study: 28712000

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate 10 gm/day
Number of subjects: 1619

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1619
Study: 26405291

Group type: EXPERIMENTAL
Intervention: AEP‐RSI (asthma educational programme based on a repeated short intervention)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: AEP‐RSI
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual clinical practice group
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Gold standard group (standard educational programme)
Number of subjects: 230
Study: 25607552

Group type: EXPERIMENTAL
Intervention: Efinaconazole topical solution, 10%
Number of subjects: 112

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 112
Study: 22731246

Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25 mg/0.1 mL)
Number of subjects: 27

Group type: COMPARATOR
Intervention: 5-Fluorouracil (5-FU)
Number of subjects: 27
Study: 18997832

Group type: EXPERIMENTAL
Intervention: ATL-104 (50, 100 or 150 mg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 17284732

Group type: EXPERIMENTAL
Intervention: Unilateral lower limb suspension for 4 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control period (4 weeks)
Number of subjects: 18
Study: 15207444

Group type: EXPERIMENTAL
Intervention: Geriatric Home Hospitalization Service (GHHS)
Number of subjects: 109

Group type: COMPARATOR
Intervention: General Medical Ward (GMW)
Number of subjects: 109
Study: 12362963

Group type: EXPERIMENTAL
Intervention: 4 sessions of acceptance and commitment therapy (ACT) plus treatment as usual (TAU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: treatment as usual (TAU)
Number of subjects: 80
Study: 9838238

Group type: EXPERIMENTAL
Intervention: Fibrin glue (2 ml applied to the axillary dissection area)
Number of subjects: 108

Group type: COMPARATOR
Intervention: No fibrin glue (control group)
Number of subjects: 108
Study: 8013699

Group type: EXPERIMENTAL
Intervention: Corneal transplantation
Number of subjects: 0
Study: 2650723

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatinum, bleomycin, vindesine, mitomycin C)
Number of subjects: 100
Study: 848228

Group type: EXPERIMENTAL
Intervention: Lumbar sympathectomy
Number of subjects: 183

Group type: COMPARATOR
Intervention: Not operated (Control)
Number of subjects: 183
Study: 30908374

Group type: EXPERIMENTAL
Intervention: Leg fatigue procedure
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trunk fatigue procedure
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition (rest)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Leg fatigue (knee extension)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trunk fatigue (trunk flexion)
Number of subjects: 24
Study: 31750743

Group type: EXPERIMENTAL
Intervention: Endoscopic plantar fascia release (EPFR)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Cryosurgery (CS)
Number of subjects: 43
Study: 31399442

Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg once daily
Number of subjects: 1545

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1545
Study: 28402866

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) - 8-week moderate-intensity exercise training, 3 sessions/week
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo exercise (PE) - 8-week light-intensity stretching, 3 sessions/week
Number of subjects: 30
Study: 26112229

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (n=59)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (n=17)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Successful dieters (n=27)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Unsuccessful dieters (n=32)
Number of subjects: 76
Study: 23219937

Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 179

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 179
Study: 22028060

Group type: EXPERIMENTAL
Intervention: Electrohysterography (EHG)
Number of subjects: 144

Group type: COMPARATOR
Intervention: External tocodynamometry (TOCO)
Number of subjects: 144
Study: 19214552

Group type: EXPERIMENTAL
Intervention: Full macular translocation (FMT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 50
Study: 17978324

Group type: EXPERIMENTAL
Intervention: Specialist out-patient treatment
Number of subjects: 167

Group type: COMPARATOR
Intervention: In-patient psychiatric treatment
Number of subjects: 167

Group type: COMPARATOR
Intervention: General out-patient treatment
Number of subjects: 167
Study: 12790762

Group type: EXPERIMENTAL
Intervention: Dosulepine (TCA) at doses of 50-250 mg
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI) at doses of 20-80 mg
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Lithium (Li) with plasma levels of 0.66±0.08 meq/l
Number of subjects: 113
Study: 11124358

Group type: EXPERIMENTAL
Intervention: Medical abortion with methotrexate 50 mg orally followed by misoprostol 800 microg vaginally
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgical abortion under local anesthesia using manual vacuum aspiration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgical abortion
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Medical abortion
Number of subjects: 50
Study: 9614721

Group type: EXPERIMENTAL
Intervention: Intrapleural instillation of low-dose streptokinase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard drainage methods
Number of subjects: 0
Study: 8335859

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 11
Study: 2877571

Group type: EXPERIMENTAL
Intervention: 40 mg famotidine at bedtime
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: 20 mg famotidine at bedtime
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 29154131

Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3)
Number of subjects: 289
Study: 27064031

Group type: EXPERIMENTAL
Intervention: Zhuanggu joint capsules combined with celecoxib capsules
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Zhuanggu joint capsules alone
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Celecoxib capsules combined with Zhuanggu joint capsule simulants
Number of subjects: 432
Study: 24882225

Group type: EXPERIMENTAL
Intervention: Culturally focused psychiatric (CFP) consultation service, two sessions
Number of subjects: 118

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 118
Study: 22186881

Group type: EXPERIMENTAL
Intervention: 16 sessions of hope‐based substance abuse treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waiting list for another term of treatment
Number of subjects: 40
Study: 20232582

Group type: EXPERIMENTAL
Intervention: copper zinc malonate lotion plus 4% hydroquinone cream (twice daily) and tretinoin cream (once daily)
Number of subjects: 42
Study: 18466615

Group type: EXPERIMENTAL
Intervention: Etoricoxib (all doses combined)
Number of subjects: 44838

Group type: EXPERIMENTAL
Intervention: Traditional nonselective NSAIDs
Number of subjects: 44838

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 44838

Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 44838

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44838
Study: 12146849

Group type: EXPERIMENTAL
Intervention: Consistent vigorous physical activity
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Sedentary activity
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Moderate physical activity
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Physical activity at any specific anatomical location in the large bowel
Number of subjects: 1905
Study: 9600495

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HS) (3.5%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (NS) (0.9%)
Number of subjects: 30
Study: 8020690

Group type: EXPERIMENTAL
Intervention: Relaxation intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Attention-placebo control intervention
Number of subjects: 20
Study: 2601834

Group type: EXPERIMENTAL
Intervention: Permanent subdural drain with subcutaneous reservoir
Number of subjects: 144

Group type: COMPARATOR
Intervention: External closed system drainage
Number of subjects: 144

Group type: COMPARATOR
Intervention: Aspiration and irrigation without any drainage
Number of subjects: 144
Study: 5386267

Group type: EXPERIMENTAL
Intervention: Dopamine eye drops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guanethidine pretreatment
Number of subjects: 0
Study: 29058477

Group type: EXPERIMENTAL
Intervention: Injection technique (IT) education with 4-mm pen needle; intensive education and reinforcement for 6 months.
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group received similar messages at study outset; no intensive education.
Number of subjects: 123
Study: 26466482

Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of 9 U rhGH every night for 7 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline applied in control group
Number of subjects: 32
Study: 23092148

Group type: EXPERIMENTAL
Intervention: Acid etching
Number of subjects: 16

Group type: COMPARATOR
Intervention: Laser etching
Number of subjects: 16
Study: 21841050

Group type: EXPERIMENTAL
Intervention: Intravenous parecoxib, 40 mg i.v.
Number of subjects: 100
Study: 19282146

Group type: EXPERIMENTAL
Intervention: New endpoint based on four ordered levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual endpoints
Number of subjects: 0
Study: 16904970

Group type: EXPERIMENTAL
Intervention: Open Repair
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Laparoscopic Repair
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Neuralgia
Number of subjects: 1603

Group type: EXPERIMENTAL
Intervention: Recurrence
Number of subjects: 1603

Group type: COMPARATOR
Intervention: Medical Outcomes Study Short Form 36
Number of subjects: 1603
Study: 15005825

Group type: EXPERIMENTAL
Intervention: Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 11579373

Group type: EXPERIMENTAL
Intervention: Group training consisting of 12 physiotherapeutic or psychologically oriented sessions
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 301
Study: 9393568

Group type: COMPARATOR
Intervention: Palliative coeliac axis intra-arterial cyclic infusions (CAI) consisting of mitoxantrone 10 mg/m2 on day 1, folinic acid 170 mg/m2 and 5-FU 600 mg/m2 during days 2-4, and cis-platinum 60 mg/m2 on day 5 for up to 11 cycles.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Adjuvant coeliac axis intra-arterial cyclic infusions (CAI) consisting of mitoxantrone 10 mg/m2 on day 1, folinic acid 170 mg/m2 and 5-FU 600 mg/m2 during days 2-4, and cis-platinum 60 mg/m2 on day 5 for up to 6 cycles.
Number of subjects: 52
Study: 8322238

Group type: EXPERIMENTAL
Intervention: Inhaled methacholine with dosimeter method (maximal dose 210 mumol)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inhaled methacholine with tidal breathing method (730 mumol)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison of dosimeter and tidal breathing methods
Number of subjects: 16
Study: 2825567

Group type: EXPERIMENTAL
Intervention: Beclomethasone aerosol (1 mg bid)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Slow-release theophylline (6.5 mg/kg bid)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Slow-release verapamil (120 mg bid)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cromolyn (20 mg qid via spinhaler)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30872546

Group type: EXPERIMENTAL
Intervention: Lateral episiotomy (4 cm cut at crowning, 1-3 cm from midline, at a 60° angle)
Number of subjects: 710

Group type: COMPARATOR
Intervention: No episiotomy
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Lateral episiotomy
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Lateral episiotomy and no episiotomy
Number of subjects: 710
Study: 28449627

Group type: EXPERIMENTAL
Intervention: 2 mg lornoxicam
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 4 mg lornoxicam
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 8 mg lornoxicam
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (10 ml isotonic 0.9% NaCl solution)
Number of subjects: 120
Study: 24434830

Group type: EXPERIMENTAL
Intervention: Psychoeducational nursing intervention
Number of subjects: 196

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 196
Study: 23920524

Group type: EXPERIMENTAL
Intervention: Training with a virtual patient (VP) simulation system
Number of subjects: 20

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 20
Study: 22096437

Group type: EXPERIMENTAL
Intervention: Dynamic Helical Hip System (DHHS)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 51
Study: 19167684

Group type: EXPERIMENTAL
Intervention: Platinum-based salvage chemotherapy, high-dose therapy, and autologous stem cell transplantation (ASCT) for PET-positive patients
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard therapy for PET-negative patients
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: All PET-positive patients
Number of subjects: 59
Study: 16394688

Group type: EXPERIMENTAL
Intervention: Open endotracheal suctioning (OES)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Closed-circuit endotracheal suctioning (CES) at -200 mmHg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Closed-circuit endotracheal suctioning (CES) at -400 mmHg
Number of subjects: 18